Fidelity International Multifactor ETF (FDEV)

I will likely buy more this week after a long time

So many investors may be missing the boat on IOVA. Despite its early missteps, it may be time to look again at taking a postion in IOVA:

https://simplywall.st/community/narratives/us/pharmaceuticals-biotech/nasdaq-iova/iovance-biotherapeutics/ismg0jwg-why-i-think-iovance-is-undervalu

Any update from PAC on the DE docket or at DTC?.
Gemini's Response:
As of today, **July 1, 2026**, there are still **no new active changes, public distribution notifications, or sudden judicial updates** on the Delaware Court of Chancery docket or from the Depository Trust Company (DTC

I always find it interesting when folks ask "how do I find" a contact, person, CEO, Marketing, email, phone number , history , DD , filings or trying to verify what
is said here instead of just doing the following.
a. Google the person
b. Google the filing
c. Look a

Are U up about 10X on this ??

Kiwi

Karen Firestone from CNBC ..ex Fidelity biotech fund manager I think
Karen Firestone (Amylyx Board Member): She is the co-founder, CEO, and Chairman of Aureus Asset Management.
She sits on the Amylyx Board as a member of both the Audit and the Nominating and Corporate Governance comm

Interesting, too, that using the MAIC actually underestimated the results, erring on the side of extreme caution in presenting the results.

I'm guessing no one, including the company, the regulators, and even (especially?) the shorts thought that applying Individual Patient Data (IPD)

Sounds like a winner to me.

$TWOH Just like OTC message boards are notorious for mentioning RS just for the heck of it

New Substack article today! Gearing up for something me thinks.

the ZRI-X's are super cool, BAD SUNNY........twice the price and for some reason............hated by vette people.......??.......and the sales and depreciation are wicked........????..........no worries, BAD SUNNY...................

produce on those UWBI cusips and I will be dropping

I think this company is dead. Very little hope left after owning it for 19 years

I will be buying more at this cheap price starting Monday morning.Our time for cheap shares is running out.

Don’t jinx it.

Every time someone says that, you turn around a year later and it’s still cheap.

That said, LC might be just have to be disappoint

Anyone else notice the bashers are promoting the glue company?
Should explain why they are here.
They'll deny it, but it's pretty obvious.
Ignore them.
Don't give them a platform.
IDE decision Monday?

Simply put, this data not only puts to rest but absolutely crushes every single bear criticism of the original trial result readout and analysis.

Even Nemisis has immediately changed his tune from “DCVax was DOA as soon as the application was submitted” to “well we still have to wait

https://www.alexandertechnologies.com/our-manufacturing-capabilities/

You are mistakenly overstating my claim which is a common problem so no harm no foul. Manufacturing transition preparedness is what I am suggesting must be in place. Artisan will be utilized to start as NWBO has consistently stated and the MIA is based on that model. Please notice that EXPANSION of

UK BNOS 2026 slides are available https://nwbio.com/wp-content/uploads/NWBT-BNOS-slides-7-3-26MB-LP-final.pdf here !!!

Slides below:

https://investorshub.advfn.com/uimage/uploads/2026/7/3/k[ferSlide1.jpg

https://investorshub.advfn.com/uimage/uploads/20

To correct myself ....:---)
What Actually Drove Guggenheim's Model Increase?
Guggenheim raised its price target on Amylyx to $40 due to structural dynamics specific to the Post-Bariatric Hypoglycemia (PBH) market rather than public diabetic trends

:Solving a Critical Co

I will be buying more at this cheap price starting Monday morning.Our time for cheap shares is running out.

Well the selling spree yesterday has made me jump to 72% cash (Highest since like late September of last year), I don't expect to be here long as I think a lot of stocks are going to sell off over the next week or two, I think in general stocks will be found 5-15% cheaper because of what I feel is a

Dr. Bosch's presentation: Very Positive!!
I attempted to recreate the chart on pg. 6 into sentences, just including the 5 yr (60 mo.) data. Go to the chart for lots more info.


Newly diagnosed GBM (survival rate):
More than doubled 5-year survival
‘Long Ta

Splurge, Go Green ZR1X Electric motor up front, AWD, 1000+ horsepower; check it out on YouTube. Will dust anything on the road, even the Bugatti Veyron. Hell buy 2or 3 great investment IMO.

Simply put, this data not only puts to rest but absolutely crushes every single bear criticism of the original trial result readout and analysis.

Even Nemisis has immediately changed his tune from “DCVax was DOA as soon as the application was submitted” to “well we still have to wait

barnstormer,

Evidently the wiring/electrical had to be reconfigured in the modified clean room space being fitted out for Class C clean room space. Best wishes.